141 related articles for article (PubMed ID: 21761463)
21. [Value of dynamic contrast-enhanced MRI in assessment of early response to neoadjuvant chemotherapy in breast cancer].
Wang XH; Peng WJ; Xin C; Tan HN; Gu YJ; Tang F; Mao J
Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):539-43. PubMed ID: 21029700
[TBL] [Abstract][Full Text] [Related]
22. Dynamic breast magnetic resonance imaging: pretreatment prediction of tumor response to neoadjuvant chemotherapy.
Dongfeng H; Daqing M; Erhu J
Clin Breast Cancer; 2012 Apr; 12(2):94-101. PubMed ID: 22169574
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of pretreatment dynamic contrast-enhanced MR imaging in breast cancer patients receiving neoadjuvant chemotherapy: overall survival predicted from combined time course and volume analysis.
Heldahl MG; Bathen TF; Rydland J; Kvistad KA; Lundgren S; Gribbestad IS; Goa PE
Acta Radiol; 2010 Jul; 51(6):604-12. PubMed ID: 20429756
[TBL] [Abstract][Full Text] [Related]
24. Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate and predict pathological response to neoadjuvant chemotherapy in patients with breast cancer?
Wu LM; Hu JN; Gu HY; Hua J; Chen J; Xu JR
Breast Cancer Res Treat; 2012 Aug; 135(1):17-28. PubMed ID: 22476850
[TBL] [Abstract][Full Text] [Related]
25. Variation of breast vascular maps on dynamic contrast-enhanced MRI after primary chemotherapy of locally advanced breast cancer.
Martincich L; Bertotto I; Montemurro F; Ponzone R; Carbonaro LA; Regge D; Sardanelli F
AJR Am J Roentgenol; 2011 May; 196(5):1214-8. PubMed ID: 21512094
[TBL] [Abstract][Full Text] [Related]
26. Magnetic resonance imaging evaluation of residual ductal carcinoma in situ following preoperative chemotherapy in breast cancer patients.
Choi HK; Cho N; Moon WK; Im SA; Han W; Noh DY
Eur J Radiol; 2012 Apr; 81(4):737-43. PubMed ID: 21300498
[TBL] [Abstract][Full Text] [Related]
27. Dynamic contrast-enhanced MRI texture analysis for pretreatment prediction of clinical and pathological response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.
Teruel JR; Heldahl MG; Goa PE; Pickles M; Lundgren S; Bathen TF; Gibbs P
NMR Biomed; 2014 Aug; 27(8):887-96. PubMed ID: 24840393
[TBL] [Abstract][Full Text] [Related]
28. DCE-MRI analysis methods for predicting the response of breast cancer to neoadjuvant chemotherapy: pilot study findings.
Li X; Arlinghaus LR; Ayers GD; Chakravarthy AB; Abramson RG; Abramson VG; Atuegwu N; Farley J; Mayer IA; Kelley MC; Meszoely IM; Means-Powell J; Grau AM; Sanders M; Bhave SR; Yankeelov TE
Magn Reson Med; 2014 Apr; 71(4):1592-602. PubMed ID: 23661583
[TBL] [Abstract][Full Text] [Related]
29. Invasive ductal breast carcinoma response to neoadjuvant chemotherapy: noninvasive monitoring with functional MR imaging pilot study.
Delille JP; Slanetz PJ; Yeh ED; Halpern EF; Kopans DB; Garrido L
Radiology; 2003 Jul; 228(1):63-9. PubMed ID: 12775851
[TBL] [Abstract][Full Text] [Related]
30. Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy.
Sharma U; Danishad KK; Seenu V; Jagannathan NR
NMR Biomed; 2009 Jan; 22(1):104-13. PubMed ID: 18384182
[TBL] [Abstract][Full Text] [Related]
31. Predicting long-term survival and treatment response in breast cancer patients receiving neoadjuvant chemotherapy by MR metabolic profiling.
Cao MD; Sitter B; Bathen TF; Bofin A; Lønning PE; Lundgren S; Gribbestad IS
NMR Biomed; 2012 Feb; 25(2):369-78. PubMed ID: 21823183
[TBL] [Abstract][Full Text] [Related]
32. Dynamic enhanced MRI predicts chemosensitivity in breast cancer patients.
Nagashima T; Sakakibara M; Nakamura R; Arai M; Kadowaki M; Kazama T; Nakatani Y; Koda K; Miyazaki M
Eur J Radiol; 2006 Nov; 60(2):270-4. PubMed ID: 16926079
[TBL] [Abstract][Full Text] [Related]
33. Multiparametric magnetic resonance imaging for predicting pathological response after the first cycle of neoadjuvant chemotherapy in breast cancer.
Li X; Abramson RG; Arlinghaus LR; Kang H; Chakravarthy AB; Abramson VG; Farley J; Mayer IA; Kelley MC; Meszoely IM; Means-Powell J; Grau AM; Sanders M; Yankeelov TE
Invest Radiol; 2015 Apr; 50(4):195-204. PubMed ID: 25360603
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the treatment response to neoadjuvant chemotherapy in locally advanced breast cancer using combined magnetic resonance vascular maps and apparent diffusion coefficient.
Wu LA; Chang RF; Huang CS; Lu YS; Chen HH; Chen JY; Chang YC
J Magn Reson Imaging; 2015 Nov; 42(5):1407-20. PubMed ID: 25875904
[TBL] [Abstract][Full Text] [Related]
35. Recurrence rates after DCE-MRI image guided planning for breast-conserving surgery following neoadjuvant chemotherapy for locally advanced breast cancer patients.
Garimella V; Qutob O; Fox JN; Long ED; Chaturvedi A; Turnbull LW; Drew PJ
Eur J Surg Oncol; 2007 Mar; 33(2):157-61. PubMed ID: 17085007
[TBL] [Abstract][Full Text] [Related]
36. Early responses assessment of neoadjuvant chemotherapy in nasopharyngeal carcinoma by serial dynamic contrast-enhanced MR imaging.
Zheng D; Yue Q; Ren W; Liu M; Zhang X; Lin H; Lai G; Chen W; Chan Q; Chen Y
Magn Reson Imaging; 2017 Jan; 35():125-131. PubMed ID: 27587228
[TBL] [Abstract][Full Text] [Related]
37. Monitoring breast cancer response to neoadjuvant systemic chemotherapy using parametric contrast-enhanced MRI: a pilot study.
Chou CP; Wu MT; Chang HT; Lo YS; Pan HB; Degani H; Furman-Haran E
Acad Radiol; 2007 May; 14(5):561-73. PubMed ID: 17434070
[TBL] [Abstract][Full Text] [Related]
38. Applying a new quantitative global breast MRI feature analysis scheme to assess tumor response to chemotherapy.
Aghaei F; Tan M; Hollingsworth AB; Zheng B
J Magn Reson Imaging; 2016 Nov; 44(5):1099-1106. PubMed ID: 27080203
[TBL] [Abstract][Full Text] [Related]
39. MRI evaluation of residual tumor size after neoadjuvant endocrine therapy vs. neoadjuvant chemotherapy.
Takeda K; Kanao S; Okada T; Ueno T; Toi M; Ishiguro H; Mikami Y; Tanaka S; Togashi K
Eur J Radiol; 2012 Sep; 81(9):2148-53. PubMed ID: 21664779
[TBL] [Abstract][Full Text] [Related]
40. MR mammography with pharmacokinetic mapping for monitoring of breast cancer treatment during neoadjuvant therapy.
Knopp MV; Brix G; Junkermann HJ; Sinn HP
Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):633-58. PubMed ID: 7489314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
